# Biomarkers and Molecular Mechanism Study of Hepatocellular Carcinoma After Radical Resection and Conversion Therapy

> **NCT06382103** · — · RECRUITING · sponsor: **Shanghai Zhongshan Hospital** · enrollment: 240 (estimated)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **DIAGNOSTIC_TEST:** ctDNA monitoring
- **DIAGNOSTIC_TEST:** Plasma proteomic analysis

## Key facts

- **NCT ID:** NCT06382103
- **Lead sponsor:** Shanghai Zhongshan Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-15
- **Primary completion:** 2025-05-20
- **Final completion:** 2026-05-20
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2025-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06382103

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06382103, "Biomarkers and Molecular Mechanism Study of Hepatocellular Carcinoma After Radical Resection and Conversion Therapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06382103. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*